HDAC9 and neoplasm: These studies have promoted investigation into the particular HDACs responsible for the differential response between transformed tissue and normal tissue, as inhibition of these HDAC isotypes will enhance tumor responsiveness to intervention, while further mitigating off-target effects of the treatment [14].